APA (7th ed.) Citation

A, R., M, D. M., C, M., A, N., JS, W., S, W., . . . E, S. (2020). Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome medicine, 12(1), 32. https://doi.org/10.1186/s13073-020-00731-8

Chicago Style (17th ed.) Citation

A, Reustle, et al. "Integrative -omics and HLA-ligandomics Analysis to Identify Novel Drug Targets for CcRCC Immunotherapy." Genome Medicine 12, no. 1 (2020): 32. https://doi.org/10.1186/s13073-020-00731-8.

MLA (9th ed.) Citation

A, Reustle, et al. "Integrative -omics and HLA-ligandomics Analysis to Identify Novel Drug Targets for CcRCC Immunotherapy." Genome Medicine, vol. 12, no. 1, 2020, p. 32, https://doi.org/10.1186/s13073-020-00731-8.